Leading pharmaceutical and healthcare companies choose Tungsten for e-invoicing

September 25, 2014  |  Adoption, Electronic Invoicing

It seems that Tungsten Network (formerly known as OB10) is the e-Invoicing provider of choice for the world’s leading pharmaceutical and healthcare companies.

The latest organisations to have selected Tungsten Network include Fresenius Medical Care (a US-based provider of kidney dialysis services and renal care products) and Dana-Farber Cancer Institute (a world leader in cancer treatment and research).

These new customers join the global e-Invoicing network alongside long-term practitioners, such as GlaxoSmithKline, and reinforce Tungsten’s strength in this industry. Seven of the twelve largest pharmaceutical companies in the world, ranked by revenue, transact with their suppliers through Tungsten Network.

Edmund Truell, Tungsten Group CEO:
“The pharmaceutical sector has been an early adopter of e-Invoicing with our first customer from the industry joining the network in 2004. It’s befitting that an industry focused on innovation is equally pioneering in its own business practices.”


Related Posts

Comments are closed.